Search research articles
Contact Us
Filters
Showing results (201-210 of 217) with videos related to
Page
of 22
Sort By:
Journal of Digestive Diseases
|
July 27, 2020
Liver damage at admission is an independent prognostic factor for COVID-19
Liu Ying Chen, Hui Kuan Chu, Tao Bai, et al.
Nucleic Acids Research
|
March 3, 2023
BACH1 deficiency prevents neointima formation and maintains the differentiated phenotype of vascular smooth muscle cells by regulating chromatin accessibility
Jieyu Guo, Jingjing Qiu, Mengping Jia, et al.
Hepatology International
|
June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
Kong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Clinical and Translational Medicine
|
February 12, 2026
NLK facilitates Caspase-8 activation to drive macrophage PANoptosis in sepsis
Yun Xia, Ren-Qi Yao, Hui-Fan Liu, et al.
Cardiovascular Research
|
June 20, 2024
Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition
Lu-Jun Zhang, Yang-Xi Hu, Rong-Zhong Huang, et al.
Science Advances
|
March 21, 2019
Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells
Xiangxiang Wei, Jieyu Guo, Qinhan Li, et al.
Frontiers in Immunology
|
March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study
Kong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
International Immunopharmacology
|
November 5, 2023
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study
Qing-Jing Chen, Kong-Ying Lin, Zhi-Wen Lin, et al.
BMC Cancer
|
December 5, 2023
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients
Kong-Ying Lin, Qing-Jing Chen, Shi-Chuan Tang, et al.
Frontiers in Oncology
|
October 20, 2025
Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resection
Jian-Xi Zhang, Luo-Bin Guo, Chong-Shi Zeng, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 217) with videos related to
Sort By:
Page
of 22
Journal of Digestive Diseases
|
July 27, 2020
Liver damage at admission is an independent prognostic factor for COVID-19
Liu Ying Chen, Hui Kuan Chu, Tao Bai, et al.
Nucleic Acids Research
|
March 3, 2023
BACH1 deficiency prevents neointima formation and maintains the differentiated phenotype of vascular smooth muscle cells by regulating chromatin accessibility
Jieyu Guo, Jingjing Qiu, Mengping Jia, et al.
Hepatology International
|
June 29, 2023
Perioperative safety, oncologic outcome, and risk factors of salvage liver resection for initially unresectable hepatocellular carcinoma converted by transarterial chemoembolization plus tyrosine kinase inhibitor and anti-PD-1 antibody: a retrospective multicenter study of 83 patients
Kong-Ying Lin, Zhi-Wen Lin, Qing-Jing Chen, et al.
Clinical and Translational Medicine
|
February 12, 2026
NLK facilitates Caspase-8 activation to drive macrophage PANoptosis in sepsis
Yun Xia, Ren-Qi Yao, Hui-Fan Liu, et al.
Cardiovascular Research
|
June 20, 2024
Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition
Lu-Jun Zhang, Yang-Xi Hu, Rong-Zhong Huang, et al.
Science Advances
|
March 21, 2019
Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells
Xiangxiang Wei, Jieyu Guo, Qinhan Li, et al.
Frontiers in Immunology
|
March 4, 2024
Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study
Kong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, et al.
International Immunopharmacology
|
November 5, 2023
Association of hepatitis B virus DNA levels with efficacy and safety outcomes in patients with hepatitis B virus-associated advanced hepatocellular carcinoma receiving tyrosine kinase inhibitor plus anti-PD-1 antibody: a multicenter propensity-matched study
Qing-Jing Chen, Kong-Ying Lin, Zhi-Wen Lin, et al.
BMC Cancer
|
December 5, 2023
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients
Kong-Ying Lin, Qing-Jing Chen, Shi-Chuan Tang, et al.
Frontiers in Oncology
|
October 20, 2025
Time to recurrence and BCLC stage at recurrence as critical variables in guiding treatment decisions for early-recurrent hepatocellular carcinoma after liver resection
Jian-Xi Zhang, Luo-Bin Guo, Chong-Shi Zeng, et al.
Page
of 22